Medicare paid an estimated $380 million over six years for organ-acquisition costs connected to organs that were not transplanted into Medicare beneficiaries, federal auditors found. The finding was not traced primarily to forged claims or hidden patients. It arose from a conflict between agency guidance and the federal statute defining which acquisition costs the program may reimburse.
The Dispute Starts Before an Organ Is Transplanted
Transplant hospitals incur costs evaluating donors, recovering organs, preserving them and coordinating placement. Medicare reimburses allowable acquisition costs through a special accounting system rather than treating every cost as part of the eventual recipient’s ordinary claim. The HHS Office of Inspector General examined whether those payments matched statutory limits.
Federal law ties Medicare reimbursement to organs transplanted into Medicare beneficiaries. Auditors concluded that conflicting Centers for Medicare & Medicaid Services guidance allowed certain costs for organs sent to non-Medicare patients or never transplanted at all. The difference turned a technical instruction into hundreds of millions of dollars in estimated program spending.
Free retirement updates: Social Security and Medicare change every year, and nobody sends you a memo. Our free Retirement Shield newsletter breaks down what changed and what to do. Get it free in your inbox.
A Sample Showed Three Different Payment Problems
In the audited sample, Medicare paid $2.8 million associated with 43 organs transplanted into people outside Medicare and 12 organs that were never transplanted. Auditors also identified $154,210 in organ-acquisition costs without adequate documentation. These are distinct findings: one concerns who ultimately received the organ, another concerns whether transplantation occurred, and the third concerns records supporting the costs.
The sample allowed OIG to project the broader six-year impact. The $380 million figure is an estimate, not an invoice-by-invoice total already recovered. It describes what Medicare likely paid because the operating guidance permitted a broader set of costs than auditors believed the statute allowed.
Conflicting Instructions Shift Risk to Hospitals
Hospitals rely on CMS manuals and reimbursement instructions to prepare cost reports. When that guidance conflicts with statutory language, a provider can follow agency directions and still face later disallowance. That makes a correction more complicated than punishing an intentionally false submission. CMS must decide how to align future instructions, how to treat past payments and how providers should allocate costs when the final recipient is not known at recovery.
Organ allocation is inherently uncertain. A recovered organ may be offered to several candidates, moved across state lines or ultimately deemed unusable. A payment rule based on the eventual recipient therefore needs a reliable reconciliation method. Without one, hospitals may record acquisition work before the facts needed to determine Medicare eligibility are final.
The Audit Is About Program Boundaries, Not Patient Bills
The report does not say transplant recipients were personally billed $380 million or that Medicare beneficiaries received organs they should not have received. It addresses payments to transplant hospitals for acquisition costs. The financial consequence falls on the Medicare trust funds and on providers that must operate under corrected reimbursement rules.
That distinction is important for beneficiaries reading an explanation of benefits. Organ-acquisition cost accounting often occurs behind the individual claim and may not appear as a comparable line on a patient’s statement. Oversight therefore depends heavily on cost reports, hospital documentation and CMS instructions rather than on a patient spotting an unfamiliar service.
CMS Now Has a Specific Rule Conflict to Resolve
OIG’s final report supplies the agency with a quantified reason to revise the guidance and strengthen documentation. The measure of success will be whether future cost reports exclude ineligible organ costs without disrupting legitimate acquisition work. As of September 15, the controlling public finding remained the six-year estimate of $380 million caused by the mismatch between CMS guidance and federal statutory requirements.
Changing the manual is only one step. Hospitals need a consistent method to identify the recipient’s insurance status after placement and to reverse or reallocate costs when an organ goes to a non-Medicare patient. Contractors reviewing cost reports need the same definition, or the conflict simply moves from national guidance into local audit decisions.
Auditors also must distinguish an ineligible category from an undocumented amount. The 43 organs used outside Medicare and the 12 never transplanted answer where the organs went. The separate $154,210 finding answers whether supporting records were adequate. Corrective work should preserve those categories so CMS can tell whether new controls fix the legal boundary, the documentation weakness or both.
The financial stakes are shared across the program. Organ procurement depends on rapid coordination, while Medicare payment law depends on traceable beneficiary eligibility. A workable correction must protect the trust funds without encouraging hospitals to delay recovery decisions or refuse organs whose final placement is uncertain.
The six-year estimate gives CMS a baseline for measuring the effect of any revision. If corrected guidance works, later cost reports should show fewer acquisition costs allocated to organs outside the Medicare beneficiary boundary. Continued sampling can test that result without assuming every transplant hospital made the same accounting decisions.
The Medicare Rules That Reach a Household Directly
Organ-acquisition accounting operates inside hospitals, while premium assistance reaches beneficiaries through separate applications. Medicare Savings Programs and Extra Help use their own income rules and are not triggered by a hospital cost-report correction.
The Benefits Checklist explains eleven programs in 69 pages, including 2026 limits and state-by-state phone contacts.
Read the Medicare assistance guide in The Benefits Checklist.
AI tools assisted in researching and drafting this article, which was reviewed prior to publication.
David M. Keller is a finance writer based in Columbus, Ohio, covering personal finance and consumer-focused economic topics. He earned his degree in journalism from Ohio University and began his career reporting on local business and economic trends for a regional media outlet. Since then, he has contributed to a variety of online publications, focusing on clear, practical coverage of topics such as cost of living, debt, and everyday financial decision-making.
